High Street Capital Acquires Avomeen
PTSM: Pharmaceutical Technology Sourcing and Management
High Street Capital acquired Avomeen, a full-service chemical testing laboratory, in late December 2016
In late December 2016, Avomeen Analytical Services announced that the company has been acquired by High Street Capital, a Chicago-based provider of flexible capital and operating expertise to middle market businesses.
Avomeen is based in Ann Arbor, MI and specializes in chemical analysis, commercial product R&D, formulation, and pharmaceutical development. In a press release, Avomeen said it plans to double in size in the next five years. Shri Thanedar, CEO of Avomeen, said he hopes to double the company’s current employment from 50 staff members to 100 in addition to doubling revenue. The company plans to hire an additional 10 to 15 scientists in the next four months.
Avomeen has provided chemical testing and analysis for the pharmaceutical, cosmetic, consumer product, health and beauty, and manufacturing industries. The company focuses on deformulation, a type of reverse engineering that identifies ingredients in complex formulations.
Source: Avomeen
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
